share_log

Forecasting The Future: 4 Analyst Projections For Gritstone Bio

Forecasting The Future: 4 Analyst Projections For Gritstone Bio

預測未來:4位分析師對gritstone bio的預測
Benzinga ·  06/14 11:01
During the last three months, 4 analysts shared their evaluations of Gritstone Bio (NASDAQ:GRTS), revealing diverse outlooks from bullish to bearish.
在過去的三個月中,有4位分析師分享了他們對Gritstone Bio(納斯達克股票代碼:GRTS)的評估,揭示了看好到看淡的不同前景。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.25, a high estimate of $5.00, and a low estimate of $3.00. This current average has decreased by 22.73% from the previous average price target of $5.50.
分析師12個月的目標價觀點揭示了平均目標價爲4.25美元,高估目標價爲5.00美元,低於目標價爲3.00美元。當前的平均目標價格已經從之前的5.50美元平均目標價格下降了22.73%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級:分析師評級的深度探討
The standing of Gritstone Bio among financial experts...
通過對分析師近期...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論